Profile data is unavailable for this security.
About the company
Japan Hospice Holdings Inc. mainly provides care for patients with end-stage cancer and those with incurable diseases with the mission of the research and dissemination of home hospices. The home hospices provided by the Company operate in the form of the provision of hospice houses and the provision of home hospice services. In the provision of hospice houses, the hospice houses operated by the Company are rental housing that tenants are limited to end-stage cancer patients and intractable diseases. In the provision of home hospice services, the Company provides home visit nursing, nursing small-scale multifunctional in-home nursing care, home nursing care support offices, visiting nursing care, in-home care, 24 hours periodic patrol and occasional correspondence visiting nursing care service.
- Revenue in JPY (TTM)11.52bn
- Net income in JPY560.60m
- Incorporated2017
- Employees963.00
- LocationJapan Hospice Holdings Inc2F, Shin Tokyo Bldg., 3-3-1, MarunouchiCHIYODA-KU 100-0005JapanJPN
- Phone+81 363684154
- Websitehttps://www.jhospice.co.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shigematsu Works Co Ltd | 13.65bn | 677.88m | 5.86bn | 386.00 | 8.54 | 0.6891 | 4.60 | 0.4295 | 95.33 | 95.33 | 1,919.14 | 1,181.28 | 0.8613 | 2.18 | 4.19 | 35,355,750.00 | 4.28 | 4.08 | 6.46 | 6.63 | 30.34 | 31.17 | 4.97 | 4.57 | 0.874 | -- | 0.3154 | 15.03 | 0.9299 | 3.87 | -21.94 | 65.70 | 9.26 | 4.56 |
Care Twentyone Corp | 44.34bn | -117.52m | 5.88bn | 5.91k | -- | 1.11 | 4.42 | 0.1326 | -8.74 | -8.74 | 3,287.74 | 355.93 | 1.23 | 748.57 | 7.60 | 7,507,782.00 | -0.3481 | 1.48 | -0.512 | 1.96 | 21.28 | 22.97 | -0.2825 | 1.43 | 1.04 | -6.38 | 0.8094 | 37.34 | 7.03 | 7.89 | -99.02 | -50.66 | 24.66 | 9.43 |
WOLVES HAND Co Ltd | 5.07bn | 522.09m | 6.42bn | 411.00 | 12.05 | 2.76 | 9.16 | 1.27 | 66.81 | 66.81 | 659.63 | 291.82 | 0.9167 | 44.93 | 24.76 | 12,325,770.00 | 9.45 | -- | 11.75 | -- | 27.00 | -- | 10.31 | -- | 0.8891 | 38.63 | 0.5737 | -- | 7.30 | -- | 10.33 | -- | -- | -- |
As Partners Co Ltd | -100.00bn | -100.00bn | 6.44bn | 811.00 | -- | 1.57 | -- | -- | -- | -- | -- | 1,150.95 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.10 | -- | 0.6002 | -- | 34.17 | -- | 145.34 | -- | -- | -- |
Japan Animal Referral Medicl Cntr Co Ltd | 4.86bn | 482.31m | 6.44bn | 256.00 | 12.46 | 1.50 | 6.40 | 1.33 | 179.73 | 179.73 | 1,806.54 | 1,497.49 | 0.5639 | 29.03 | 17.74 | 18,973,350.00 | 5.60 | 4.59 | 6.51 | 5.40 | 35.66 | 36.01 | 9.93 | 9.60 | 0.9748 | 32.17 | 0.4964 | 3.36 | 10.26 | 10.74 | -11.41 | 2.72 | 59.84 | -- |
Uchiyama Holdings Co Ltd | 29.07bn | 322.22m | 6.75bn | 2.27k | 18.76 | 0.4804 | 7.05 | 0.232 | 16.63 | 16.63 | 1,500.74 | 649.51 | 0.9419 | 111.39 | 11.21 | 12,812,240.00 | 1.04 | -2.04 | 1.49 | -2.76 | 6.95 | 5.43 | 1.11 | -2.27 | 1.81 | 12.65 | 0.5125 | -- | 7.18 | 1.17 | 153.40 | -27.96 | -9.99 | 0.00 |
Japan Hospice Holdings Inc | 11.52bn | 560.60m | 11.20bn | 963.00 | 20.26 | 3.47 | 11.90 | 0.9721 | 67.19 | 67.19 | 1,383.49 | 392.09 | 0.721 | -- | 6.62 | 11,967,290.00 | 3.51 | 4.43 | 4.15 | 5.29 | 16.35 | 19.68 | 4.86 | 5.49 | -- | 2.78 | 0.8016 | 0.00 | 25.05 | 26.77 | 49.95 | 35.47 | 87.38 | -- |
Advantage Risk Management Co., Ltd. | 7.22bn | 333.93m | 11.79bn | 439.00 | 34.87 | 3.28 | 11.04 | 1.63 | 19.56 | 19.56 | 437.58 | 207.67 | 0.9466 | -- | 7.07 | 16,438,620.00 | 4.38 | 7.72 | 7.25 | 12.15 | 70.75 | 74.07 | 4.63 | 7.42 | -- | -- | 0.3841 | 40.52 | 9.26 | 7.40 | 33.89 | -3.84 | 36.78 | 3.71 |
StemCell Institute Inc | 2.64bn | 423.14m | 16.04bn | 98.00 | 37.90 | 5.59 | 29.19 | 6.07 | 41.30 | 41.30 | 257.79 | 280.15 | 0.4039 | 25.62 | 1.67 | 26,953,570.00 | 6.47 | 4.23 | 15.30 | 10.85 | 63.42 | 64.40 | 16.02 | 10.41 | 1.30 | -- | 0.00 | 0.00 | 18.64 | 16.63 | 57.04 | 16.84 | 46.68 | -- |
Holder | Shares | % Held |
---|---|---|
Daiwa Asset Management Co. Ltd.as of 15 Aug 2024 | 647.50k | 7.87% |
Asset Management One Co., Ltd.as of 29 Mar 2024 | 368.30k | 4.47% |
Rheos Capital Works, Inc. (Investment Management)as of 02 Oct 2023 | 107.20k | 1.30% |
Dimensional Fund Advisors LPas of 07 Nov 2024 | 71.50k | 0.87% |
Schroder Investment Management (Japan) Ltd.as of 31 Jul 2024 | 59.10k | 0.72% |
BNY Mellon Investment Management Japan Ltd.as of 17 Oct 2023 | 56.50k | 0.69% |
Nomura Asset Management Co., Ltd.as of 30 Oct 2023 | 55.30k | 0.67% |
Ichiyoshi Asset Management Co., Ltd.as of 05 Dec 2023 | 54.60k | 0.66% |
Carrera Asset Management Co., Ltd.as of 15 Nov 2023 | 50.00k | 0.61% |
Atlantis Investment Research Corp.as of 30 Aug 2024 | 30.00k | 0.36% |